Radiation therapy of sinonasal natural killer/T-cell lymphoma

被引:2
作者
Riet, F. -G. [1 ]
Canova, C. -H. [1 ]
Gabarre, J. [2 ]
Ben Hassine, S. [1 ]
Kom, L. Kamsu [1 ]
Mazeron, J. -J. [1 ]
Feuvret, L. [1 ]
机构
[1] Grp Hosp Pitie Salpetriere, AP HP, Serv Oncol Radiotheapie, F-75651 Paris 13, France
[2] Grp Hosp Pitie Salpetriere, AP HP, Serv Hepatol, F-75651 Paris 13, France
来源
CANCER RADIOTHERAPIE | 2014年 / 18卷 / 02期
关键词
Natural killer (NK)/T-cell lymphoma; Nasal cavity; Radiation therapy; Chemotherapy; Combined chemoradiation; INTENSITY-MODULATED RADIOTHERAPY; WORLD-HEALTH-ORGANIZATION; INTERNATIONAL PROGNOSTIC INDEX; STAGE NASOPHARYNGEAL CARCINOMA; INVOLVED-FIELD RADIATION; ANGIOCENTRIC T-CELL; NASAL-TYPE; (NK)/T-CELL LYMPHOMA; SMILE CHEMOTHERAPY; SINGLE-CENTER;
D O I
10.1016/j.canrad.2013.11.009
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Natural killer (NK)/T-cell lymphoma are part of lymphoproliferative diseases, they are rare in Europe and the United States but relatively common in Asia and South America. Natural killer (NK)/T-cell lymphoma present clinically as destructive lesions of the upper aerodigestive tract with perforation of deep structures of the face, destruction of the palate or an invasion of orbits. Treatment modalities of these lymphomas are still discussed because of the lack of available studies and the rarity of this disease. Radiotherapy provides a rapid control of the disease and is positioned as a major treatment of localized stages of NK/T-cell lymphoma of the nasal cavity. We therefore studied the different forms of radiation therapy in the early stages of nasal NK/T-cell lymphoma. (C) 2013 Societe francaise de radiotherapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:147 / 153
页数:7
相关论文
共 50 条
  • [31] Efficacy of Frontline Chemotherapy for Extranodal Natural Killer/T-Cell Lymphoma: A Systematic Review and Network Meta-Analysis
    Luo, Fei
    Wang, Jing Nan
    Liu, Xin
    Wang, Xin
    Qi, Shu Nan
    Li, Ye Xiong
    JOURNAL OF HEMATOLOGY, 2023, 12 (05) : 215 - 226
  • [32] Updating targets for natural killer/T-cell lymphoma immunotherapy
    Xue, Weili
    Zhang, Mingzhi
    CANCER BIOLOGY & MEDICINE, 2021, 18 (01) : 52 - 62
  • [33] Clinical Features and Current Optimal Management of Natural Killer/T-Cell Lymphoma
    Makita, Shinichi
    Tobinai, Kensei
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2017, 31 (02) : 239 - 253
  • [34] Chemoradiotherapy for localized extranodal natural killer/T-cell lymphoma, nasal type, using a shrinking-field radiation strategy: multi-institutional experience
    Hattori, Yukiko
    Murai, Taro
    Iwata, Hiromitsu
    Uchiyama, Kaoru
    Mimura, Mikio
    Kato, Eriko
    Murata, Rumi
    Shibamoto, Yuta
    JAPANESE JOURNAL OF RADIOLOGY, 2016, 34 (04) : 292 - 299
  • [35] Tislelizumab and radiation therapy in low-risk early-stage extranodal natural killer/T-cell lymphoma, nasal type: a phase II study protocol
    Li, Jia-Ying
    Qi, Shu-Nan
    Hu, Chen
    Liu, Xin
    Yang, Yong
    Wu, Tao
    Zheng, Rong
    Feng, Xiao-Li
    Ni, Xiao-Guang
    Jin, Feng-Yan
    Song, Yu-Qin
    Liu, Wei-Ping
    Zhou, Sheng-Yu
    Li, Ye-Xiong
    FUTURE ONCOLOGY, 2024, 20 (05) : 245 - 256
  • [36] Predictive value of pre-treatment T lymphocyte subsets in patients with extranodal natural killer/T-cell lymphoma
    Lu, Xingmei
    Huang, Kate
    Chen, Suidan
    Ji, Xiuhuan
    Li, Peng
    ANNALS OF HEMATOLOGY, 2024, 103 (11) : 4621 - 4635
  • [37] Utility of PET/CT in the Diagnosis and Staging of Extranodal Natural Killer/T-Cell Lymphoma A Systematic Review and Meta-Analysis
    Zhou, Xiangxiang
    Lu, Kang
    Geng, Lingyun
    Li, Xinyu
    Jiang, Yujie
    Wang, Xin
    MEDICINE, 2014, 93 (28) : e258
  • [38] Identifying high-risk patients with natural killer/T-cell lymphoma undergoing autologous stem cell transplantation
    Bai, Bing
    Gao, Yan
    Wang, Xiao-Xiao
    He, Hai-Xia
    Ping, Li-Qin
    Li, Peng-Fei
    Huang, Cheng
    Cai, Qi-Chun
    Huang, Hui-Qiang
    LEUKEMIA & LYMPHOMA, 2020, 61 (14) : 3404 - 3411
  • [39] A novel prognostic model for extranodal natural killer/T-cell lymphoma
    Jia-Jia Huang
    Ying-Jie Zhu
    Yi Xia
    Wei Zhao
    Tong-Yu Lin
    Wen-Qi Jiang
    Hui-Qiang Huang
    Zhi-Ming Li
    Medical Oncology, 2012, 29 : 2183 - 2190
  • [40] Towards Next Generation Biomarkers in Natural Killer/T-Cell Lymphoma
    Chan, Jason Yongsheng
    Lim, Jing Quan
    Ong, Choon Kiat
    LIFE-BASEL, 2021, 11 (08):